ciprofloxacin has been researched along with cephalexin in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.56) | 18.7374 |
1990's | 4 (10.26) | 18.2507 |
2000's | 9 (23.08) | 29.6817 |
2010's | 22 (56.41) | 24.3611 |
2020's | 3 (7.69) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Jones, GL; Stickler, DJ | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Avdeef, A; Tam, KY | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Grime, K; Paine, SW | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Agrahari, AK; Rajkhowa, S; Sharma, A; Tiwari, VK | 1 |
Baxter, R; Chapman, J; Drew, WL | 1 |
Jórasz, J; Ktos, K; Polubiec, A; Stepka, K; Strazynska, R; Weuta, H | 1 |
Jayaprakash, DG; Krishnamurthy, L; Menon, PK; Raman, TS; Singh, D | 1 |
Dotters, DJ; James, AH; Katz, VL; Rogers, RG | 1 |
Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
Dunstan, FD; Fitzgerald, KA; Howard, AJ; Magee, JT | 1 |
Honkanen-Buzalski, T; Lehtolainen, T; Pyörälä, S; Shpigel, NY; Shwimmer, A | 1 |
Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
Al-Azzam, SI; Alzoubi, KH; Masadeh, MM; Mhaidat, NM | 1 |
Kelly, AM; Swanson, AN; Wanich, T; Wyatt, AJ | 1 |
Caramia, G; Ruffini, E | 1 |
Brum, DM; Caldas, LF; Cassella, RJ; de Paula, CE | 1 |
Cartwright, R; Derpapas, A; Fernando, R; Gallo, P; Khullar, V; Vijaya, G | 1 |
Hammert, WC; Richardson, WL | 1 |
Hunter-Ellul, LA; Martin, JE; Philips, RC; Wilkerson, MG | 1 |
Dalsgaard, A; Phu, TM; Phuong, NT; Scippo, ML | 1 |
Popa, D; Van Hoesen, K | 1 |
Lee, JS; Pan, JY; Tan, M | 1 |
Ansari, L; Haghani, M; Masoomi, S; Momeni, F; Mortazavi, SA; Mortazavi, SMJ; Movahedi, MM; Ranjbar, S; Taeb, S; Taheri, M; Tajbakhsh, S; Zarei, S | 1 |
Barry, L; Corcoran, GD; Hooton, C; Lucey, B; O'Grady, MC; O'Halloran, C; Walsh, N | 1 |
Pavich, E; Vogler, S | 1 |
Avison, M; Batty, C; de Lacy Costello, B; Persad, R; Ratcliffe, N; Smart, A; Turner, C; White, P | 1 |
Crawford, SB; Davis, WH; Geno, KA; Magee, MR; Monks, SM | 1 |
Denny, JC; Forest, K; Gu, S; Larson, EA; Rajendiran, G; Tran, TC; Wilke, RA | 1 |
6 review(s) available for ciprofloxacin and cephalexin
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Emerging impact of triazoles as anti-tubercular agent.
Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Pyoderma gangrenosum following patellar tendon repair: a case report and review of the literature.
Topics: Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Dapsone; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Middle Aged; Patellar Ligament; Postoperative Complications; Prednisone; Pyoderma Gangrenosum; Rupture; Treatment Outcome; Wound Healing | 2012 |
[Proper antibiotic therapy. From penicillin to pharmacogenomic].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Chloramphenicol; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Evidence-Based Medicine; Genetic Testing; Genetic Variation; Hospitals; Humans; Microbial Sensitivity Tests; Penicillins; Pharmacogenetics; Practice Patterns, Physicians'; Streptomycin; Tetracyclines | 2012 |
Adverse effects of common oral antibiotics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Ciprofloxacin; Clindamycin; Hand; Hand Dermatoses; Humans; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
1 trial(s) available for ciprofloxacin and cephalexin
Article | Year |
---|---|
Bacterial infections of the lower urinary tract treated with ciprofloxacin or cefalexin--a comparative study.
Topics: Adult; Bacterial Infections; Cephalexin; Ciprofloxacin; Clinical Trials as Topic; Humans; Random Allocation; Urinary Tract Infections | 1988 |
32 other study(ies) available for ciprofloxacin and cephalexin
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Reduced Susceptibility of Proteus mirabilis to triclosan.
Topics: Anti-Infective Agents, Local; Biofilms; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Anatomic; Mutation; Proteus mirabilis; Triclosan; Urinary Bladder; Urinary Catheterization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Body Weight; Dogs; Drug Administration Routes; Humans; Liver; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Pharmaceutical Preparations; Protein Binding; Rats; Species Specificity | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Comparison of bactericidal activity of five antibiotics against Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clindamycin; Dicloxacillin; Female; Humans; Male; Middle Aged; Serum Bactericidal Test; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Clinical profile and therapy in enteric fever.
Topics: Cephalexin; Child, Preschool; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; Humans; Infant; Prospective Studies; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1994 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cefoxitin; Cephalexin; Cephalosporins; Cephamycins; Ciprofloxacin; Clindamycin; Clostridioides difficile; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fever; Gentamicins; Humans; Imipenem; Incidence; Middle Aged; Nausea; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 1997 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cephalexin; Cephradine; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim; Urinary Tract Infections | 2001 |
In vitro antimicrobial susceptibility of Escherichia coli isolates from clinical bovine mastitis in Finland and Israel.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Cephalexin; Ciprofloxacin; Dihydrostreptomycin Sulfate; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Female; Finland; Gentamicins; Israel; Mastitis, Bovine; Microbial Sensitivity Tests; Sulfadiazine; Tetracycline; Trimethoprim | 2003 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Investigation of the antibacterial activity of pioglitazone.
Topics: Amoxicillin; Anti-Bacterial Agents; Cell Proliferation; Cephalexin; Ciprofloxacin; Drug Synergism; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Hypoglycemic Agents; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pioglitazone; Streptococcus pneumoniae; Thiazolidinediones; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Development of an ultrasonic slurry sampling method for the determination of Cu and Mn in antibiotic tablets by electrothermal atomic absorption spectrometry.
Topics: Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Copper; Manganese; Quality Control; Sonication; Spectrophotometry, Atomic; Tablets | 2012 |
Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder.
Topics: Adult; Anti-Bacterial Agents; Biomarkers; Cephalexin; Ciprofloxacin; Cohort Studies; Doxycycline; Female; Humans; Middle Aged; Nerve Growth Factor; Prospective Studies; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Urinary Bladder, Overactive | 2013 |
Mycobacterium fortuitum infection arising in a new tattoo.
Topics: Adult; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clarithromycin; Cosmetic Techniques; Drug Therapy, Combination; Humans; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Tattooing; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Quality of Antimicrobial Products Used in Striped Catfish (Pangasianodon hypophthalmus) Aquaculture in Vietnam.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Aquaculture; Catfishes; Cephalexin; Ciprofloxacin; Doxycycline; Quality Control; Reference Standards; Sulfonamides; Thiamphenicol; Trimethoprim; Veterinary Drugs; Vietnam | 2015 |
A "Shark Encounter": Delayed Primary Closure and Prophylactic Antibiotic Treatment of a Great White Shark Bite.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aquatic Organisms; Cephalexin; Ciprofloxacin; Diving; Humans; Male; Mexico; Middle Aged; Open Bite; Sharks; Thigh; Wound Closure Techniques | 2016 |
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.
Topics: Actinomycosis; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clindamycin; Coinfection; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Male; Pseudomonas Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Thigh; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Sensitivity to Antibiotics of Bacteria Exposed to Gamma Radiation Emitted from Hot Soils of the High Background Radiation Areas of Ramsar, Northern Iran.
Topics: Anti-Bacterial Agents; Background Radiation; Cephalexin; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gamma Rays; Iran; Klebsiella pneumoniae; Nitrofurantoin; Salmonella typhimurium; Soil; Staphylococcus aureus | 2017 |
Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cephalexin; Cephradine; Ciprofloxacin; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2018 |
Pyelonephritis treatment in the community emergency department: Cephalosporins vs. first-line agents.
Topics: Adult; Anti-Bacterial Agents; Cefdinir; Cephalexin; Ciprofloxacin; Drug Resistance, Bacterial; Emergency Service, Hospital; Female; Hospitals, Community; Humans; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Retrospective Studies; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
Sniffing out resistance - Rapid identification of urinary tract infection-causing bacteria and their antibiotic susceptibility using volatile metabolite profiles.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Proof of Concept Study; Pseudomonas aeruginosa; Urinary Tract Infections; Volatile Organic Compounds | 2019 |
Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cefuroxime; Cephalexin; Ciprofloxacin; Emergency Service, Hospital; Fluoroquinolones; Humans; Levofloxacin; Mexico; Nitrofurantoin; Retrospective Studies; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2022 |
Drug-Induced Liver Injury with Commonly Used Antibiotics in the All of Us Research Program.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cephalexin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Humans; Population Health; Retrospective Studies; United States | 2023 |